EP3412278 - PHARMACEUTICAL DOSAGE FORMS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.11.2020 Database last updated on 16.11.2024 | |
Former | Grant of patent is intended Status updated on 11.02.2020 | ||
Former | Request for examination was made Status updated on 22.11.2019 | ||
Former | Grant of patent is intended Status updated on 24.07.2019 | ||
Former | Request for examination was made Status updated on 21.06.2019 | ||
Former | The application has been published Status updated on 09.11.2018 | Most recent event Tooltip | 20.11.2020 | Application deemed to be withdrawn | published on 23.12.2020 [2020/52] | Applicant(s) | For all designated states Recordati AG Lindenstrasse 8 6340 Baar / CH | [2020/10] |
Former [2018/50] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | Inventor(s) | 01 /
BEATO, Stefania Novartis Pharma AG Postfach 4002 Basel / CH | 02 /
QUINTON, Peggy Novartis Pharma AG Postfach 4002 Basel / CH | [2018/50] | Representative(s) | Pistolesi, Roberto, et al Dragotti & Associati Srl Via Nino Bixio, 7 20129 Milano / IT | [N/P] |
Former [2018/50] | Petersen, Holger Novartis Pharma AG Postfach 4002 Basel / CH | Application number, filing date | 18176177.6 | 06.07.2015 | [2018/50] | Priority number, date | US201462021271P | 07.07.2014 Original published format: US 201462021271 P | [2018/50] | Previously filed application, date | WO2015IB55098 | 06.07.2015 | [2018/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3412278 | Date: | 12.12.2018 | Language: | EN | [2018/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.10.2018 | Classification | IPC: | A61K9/20, A61K31/45 | [2018/50] | CPC: |
A61K9/2036 (EP,EA,IL,KR,US);
A61K9/2054 (EP,CN,EA,IL,KR,US);
A61K9/0053 (CN,EA,IL);
A61K31/4188 (CN,EA,IL,US);
A61K31/4184 (EP,EA,IL,US);
A61K31/45 (EA,IL,KR);
A61K9/20 (IL);
A61K9/2009 (EA,IL,US);
A61K9/2095 (EA,IL,US);
A61K9/2806 (CN,EA,IL);
A61K9/2813 (EA,IL,US);
A61K9/2826 (EA,IL,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/30] |
Former [2018/50] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | DOSIERFORMEN FÜR ARZNEIMITTEL | [2018/50] | English: | PHARMACEUTICAL DOSAGE FORMS | [2018/50] | French: | FORMES PHARMACEUTIQUES | [2018/50] | Examination procedure | 07.06.2019 | Amendment by applicant (claims and/or description) | 12.06.2019 | Examination requested [2019/30] | 12.06.2019 | Date on which the examining division has become responsible | 25.07.2019 | Communication of intention to grant the patent | 21.11.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 12.02.2020 | Communication of intention to grant the patent | 23.06.2020 | Application deemed to be withdrawn, date of legal effect [2020/52] | 05.08.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2020/52] | Parent application(s) Tooltip | EP15738484.3 / EP3166596 | Fees paid | Renewal fee | 16.11.2018 | Renewal fee patent year 03 | 16.11.2018 | Renewal fee patent year 04 | 15.07.2019 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.07.2020 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]WO2011088188 (NOVARTIS AG [CH], et al) [AD] 1-18* example -; claim - *; | [A]WO2013153129 (NOVARTIS AG [CH], et al) [A] 1-18 * example -; claim - *; | [AP]EP2815749 (IP GES FÜR MAN MBH [DE]) [AP] 1-18 * paragraphs [0008] , [0025] - [0028] - [0051] - [0078] - [0096] , [0121] , [0167] , [0296] - [0298] * * example 20 * * claim - * | by applicant | WO2007024945 | WO2011088188 | WO2013109514 |